Overall, this study enhances our understanding of the immunological events characterising the preclinical stage of type 1 diabetes, highlighting sPD-1 as a relevant pathophysiological molecule involved in the mechanisms at the root of type 1 diabetes development and progression. The gene discussed is HOXD13; the disease is type 1 diabetes mellitus.